Standard delivery is 1-2 working days
 
Free delivery over £550 (excludes cold chain)
01376 532800
Register
Products
Clearance & Promotions
Galderma
Training
Brands
ePharmacy
News
Contact Us

This content has been developed by Galderma and is intended for Healthcare Professionals Only

Sculptra is the first and original PLLA injectable collagen stimulator that helps produce natural collagen, which can gradually restore the skin’s inner structure to smooth wrinkles and improve skin quality for up to 2 years.1-5

Because ageing is universal

Sculptra targets collagen loss as patients age, remodelling the extracellular matrix (ECM)1,6,7

Because Sculptra is unique

With a unique stimulation process, only Sculptra is proven to stimulate collagen type-18,9,11

The Sculptra PLLA-SCA is made the unique “Sculptra way”10

Sculptra has a unique stimulation process and shows a regenerative pathway unlike CaHA-R1,7-9,11

Because Sculptra is unmatched

Sculptra gives patients firm, radiant skin for a natural, rejuvenated appearance for up to 25 months3-5

Sculptra has high patient satisfaction for up to 2 years3,15

For 25 years, Sculptra has had an unmatched proven safety profile and efficacy12-14

The anticipated injection related reactions include transient bleeding
from the needle stick, pain, localised redness, bruising, haematoma, or
oedema, which generally resolve within 2–6 days.16

Please refer to the instructions for use within the product packaging prior to
use for full information on contraindications, adverse events and precautions.

View All

References: 1. Goldberg D, et al. Dermatol Surg. 2013;39(6):915–922. 2. Data on file. 43USSA1812 Clinical study report. Fort Worth, TX: Galderma Laboratories, L.P. 2022. 3. Fabi S, et al. Poster presented at the International Master Course on Aging Science (IMCAS) World Congress. 26–28 January 2023. Paris, France. 4. Narins RS, et al. J Am Acad Dermatol. 2010;62(3):448–462. 5. Brandt FS, et al. Aesthet Surg J. 2011;31(5):521–528. 6. Fitzgerald R et al. Aesthet Surg J. 2018;38(suppl_1):S13-S1. 7. Data on File (MA-58025). 8. Lacombe V. Facial Plast Surg. 2009;25(2):95–99; 9. Filho CDSM, et al. Surg Cosmet Dermatol. 2013;5(4):345–350. 10. Asius J, et al. Inventors. US patent US 7,731,758 B2.2010. 11. Widgerow A et al. Poster presented at the International Master Course on Aging Science (IMCAS) World Congress. 01-03 February 2024. Paris, France. 12. Rayess HM et al. JAMA Facial Plast Surg. 2018;20(3):207-214. 13. Data on File (MA-54105). 14. Data on File (MA-47133). 15. Brown SA, et al. Plast Reconstr Surg. 2011;127(4):1684–1692. 16. Sculptra EU IFU.

 

Adverse events should be reported. For the UK, Reporting forms and information can be found at
www.mhra.gov.uk/yellowcard or search for Yellow Card in the Google Play or Apple App Store.

For Ireland, Suspected adverse events can be reported via HPRA Pharmacovigilance, Website:
www.hpra.ie; Adverse events should also be reported to Galderma (UK) Ltd,
Email: medinfo.uk@galderma.com Tel: +44 (0) 300 3035674


UKI-SCU-2400022 DOP April 2024